Advertisement

Von Willebrand Factor, Dysfunction of the Vascular Endothelium, and the Development of Renal and Vascular Complications in Diabetes

  • Coen D. A. Stehouwer

Abstract

Both in IDDM [1–4] and in NIDDM [5–11], the presence of microalbuminuria or clinical proteinuria identifies a group of patients at very high risk of developing severe vascular complications, i.e. proliferative retinopathy, renal insufficiency, and cardiovascular disease. Several hypotheses have been advanced to explain why an increased urinary albumin excretion rate should be associated with an excess of extrarenal complications [1,12–14]. This chapter will discuss the role of von Willebrand factor (vWF), a haemostatic glycoprotein synthesised by endothelial cells and megakaryocytes, and of dysfunction of the vascular endothelium.

Keywords

Endothelial Dysfunction Platelet Adhesion Urinary Albumin Excretion Endothelial Injury Insulin Resistance Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Deckext T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989; 32:219–226CrossRefGoogle Scholar
  2. 2.
    Parving HH, Hommel E, Mathiesen ER, et al. Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin-dependent diabetes. BMJ 1988;296:156–160.PubMedCrossRefGoogle Scholar
  3. 3.
    Krolewski AS, Kosinski EJ, Warram JH, et al. Magnitude and determinants of coronary disease in juvenile onset insulin-dependent diabetes mellitus. Am J Cardiol 1987; 59:750–755.PubMedCrossRefGoogle Scholar
  4. 4.
    Deckert T, Yokoyama H, Mathiesen E, et al. Cohort study of predictive value of urinary albumin excretion for atherosclerotic vascular disease in patients with insulin dependent diabetes. BMJ 1996, 312:871–874.PubMedCrossRefGoogle Scholar
  5. 5.
    Dimieen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 1997; 157:1413–1418.CrossRefGoogle Scholar
  6. 6.
    Nelson RG, Pettitt DJ, Carraher MJ, Baird HR, Knowler WC. Effect of proteinuria on mortality in non-insulin dependent diabetes mellitus. Diabetes 1988; 37:1499–1504.PubMedCrossRefGoogle Scholar
  7. 7.
    Gall MA, Rossing P, Skott P, et al. Prevalence of micro- and macroalbumrnuria, arterial hypertension, retinopathy and large vessel disease in European Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991; 34:655–661.PubMedCrossRefGoogle Scholar
  8. 8.
    Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE. Eight-nine year mortality in known non-insulin-dependent diabetes and controls. A prospective study. Kidney Int. 1992; 41:731–735.PubMedCrossRefGoogle Scholar
  9. 9.
    Mattock MB, Morrish NJ, Viberti GC, Keen H, Fitzgerald AP, Jackson G. Prospective study of microalbuminuria as predictor of mortalitity in non-tnsulin-dependent diabetes mellitus. Diabetes 1992;41:736–741.PubMedCrossRefGoogle Scholar
  10. 10.
    Stehouwer CDA, Nauta JJP, Zeldenrust GC, Hackeng WHL, Donker AJM, den Ottolander GJH. Albuminuria, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 1992; 340:319–323.PubMedCrossRefGoogle Scholar
  11. 11.
    Gall M-A, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving H-H. Albuminuria and poor glycemic control predict mortality in non-insulin-dependent diabetes mellitus. Diabetes 1995; 44:1301–1309.CrossRefGoogle Scholar
  12. 12.
    DeFronzo RA, Ferranini E. Insulin resistance: A mukifaced syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atheroslerotic cardiovascular disease. Diabetes Care 1991;14:173–194.PubMedCrossRefGoogle Scholar
  13. 13.
    Stehouwer CDA, Donker AJM : Urinary albumin excretion and cardiovascular disease risk in diabetes mellitus9 Is endothelial dysfunction the missing link? J Nephrol 1993; 6:72–92.Google Scholar
  14. 14.
    Stehouwer CDA, Schaper NC. The pathogenesis of vascular complications of diabetes mellitus: One voice or many? Eur J Clin Invest 1996; 26:535–543.PubMedCrossRefGoogle Scholar
  15. 15.
    Jensen T. Increased plasma level of von Willebrand factor in type 1 (insulin-dependent) diabetic patients with incipient nephropathy. BMJ 1989; 298:27–28.PubMedCrossRefGoogle Scholar
  16. 16.
    Stehouwer CDA, Stroes ESG, Hackeng WHL, Mulder PGH, den Ottolander GJH. von Willebrand factor and development of diabetic nephropathy in insulin-dependent diabetes mellitus. Diabetes 1991; 40:971–976[erratum,Diabetes 1991; 40:1746].PubMedCrossRefGoogle Scholar
  17. 17.
    Schmitz A, Ingerslev J. Haemostatic measures in Type 2 diabetic patients with microalbuminuria Diabetic Med 1990; 7:521–525.CrossRefGoogle Scholar
  18. 18.
    Collier A, Rumley A, Rumley AG, et al. Free radical activity and hemostatic factors in NIDDM patients with and without microalbuminuria. Diabetes 1992;41:909–913.PubMedCrossRefGoogle Scholar
  19. 19.
    Stehouwer CDA, Fischer HRA, van Kuijk AWR, Polak BCP, Donker AJM. Endothelial dysfunction precedes develoment of microalbuminuria in insulin-dependent diabetes mellitus. Diabetes 1995; 44:561–564.PubMedCrossRefGoogle Scholar
  20. 20.
    Chen JW, Gall M-A, Deckert M, Jensen JS, Parving H-H. Increased serum concentration of von Willebrand factor in non-insulin-dependent diabetic patients with and without diabetic nephropathy. BMJ 1995; 311:1405–1406.PubMedCrossRefGoogle Scholar
  21. 21.
    Stehouwer CDA, Zellenrath P, Polak BCP, et al. von Willebrand factor and early diabetic retinopathy: No evidence for a relationship in patients with Type 1 (insulin-dependent) diabetes mellitus and normal urinary albumin excretion. Diabetologia 1992; 35:555–559.PubMedCrossRefGoogle Scholar
  22. 22.
    Meyer D, Girma JP. : von Willehrand factor Structure and function. Thromb Haemost 1993; 70:111–118.Google Scholar
  23. 23.
    Wagner DD. The Weibel-Palade body: The storage granule for von Willebrand factor and P-selectin. Thromb Haemost 1993; 70:105–110.PubMedGoogle Scholar
  24. 24.
    Collier A, Leach JP, McLellan A, Jardine A, Morton JJ, Small M Plasma endothelmlike immunoreactivity levels in insulin-dependent mellitus patients with microalbuminuria. Diabetes Care 1992; 15:1038–1040.PubMedCrossRefGoogle Scholar
  25. 25.
    Elliot TG, Cockcroft JR, Groop PH, Viberti GC, Ritter JM. Inbition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci 1993; 83:687–693Google Scholar
  26. 26.
    Stehouwer CDA, Lambert J, Donker AJM, van Hinsbergh VWM. Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 1997; 34: 55–68.PubMedCrossRefGoogle Scholar
  27. 27.
    Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993; 362:801–809.PubMedCrossRefGoogle Scholar
  28. 28.
    Diamond JR, Karnovsky MJ. Focal and segmental glomerulosclerosis: analogies to atherosclerosis. Kidney Int 1988; 33: 917–924.PubMedCrossRefGoogle Scholar
  29. 29.
    McVeigh GE, Brennan GM, Johnston GD, et al. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992; 35:771–776.PubMedGoogle Scholar
  30. 30.
    Ting HH, Timini FK, Boles KS, Creager SJ, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin dependent diabetes mellitus. J Clin Invest 1996; 97:22–28.PubMedCrossRefGoogle Scholar
  31. 31.
    Goodfellow J, Ramsey MW, Luddington LA, et al. Endothelium and inelastic arteries: an early marker of vascular dysfunction in non-insulin-dependent diabetes. BMJ 1996; 312:744–745.PubMedCrossRefGoogle Scholar
  32. 32.
    Strandl E, Balletshofer B, Dahl B, et al. Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: The Munich General Practitioner Project Diabetologia 1996; 39:1540–1545.Google Scholar
  33. 33.
    Plater ME, Ford I, Dent MT, Preston FE, Ward JE. Elevated von Willebrand factor antigen predicts deterioration in diabetic periperal nerve function. Diabetologia 1996; 39:336–343.PubMedCrossRefGoogle Scholar
  34. 34.
    Juhan-Vague I, Vague P. “Hyperinsulinemia and its effects of coagulation and fibrinolysis in cardiovascular diseasae”. In Atherosclerotic Cardiovascular Disease, Hemostasis and Endothelial Function. Francis RB, ed. New York: Marcel Dekker, 1992; pp 141–182.Google Scholar
  35. 35.
    Carver A, Collier J, Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 1992; 90:2548–2554.CrossRefGoogle Scholar
  36. 36.
    Smits P, Kapma J, Jacobs MC, Lutterman J, Thien T. Endothelium-dependent vascular relaxation in patients with type 1 diabetes. Diabetes 1993; 42: 148–153.PubMedCrossRefGoogle Scholar
  37. 37.
    Smulders RA, Stehouwer CDA, Olthof GC, et al. Plasma endothelin levels and vascular effects of intravenous L-arginine infusion in subjects with uncomplicated insulin-dependent diabetes mellitus. Clin Sci. 1994; 87:37–43.PubMedGoogle Scholar
  38. 38.
    Kool MJF, Lambert J, Stehouwer CDA, Hoeks APG, Struijker Boudier HAJ, van Bortel LMAB. Vessel wall properties of large arteries in uncomplicated insulin-dependent diabetes mellitus. Diabetes Care 1995; 18: 618–624.PubMedCrossRefGoogle Scholar
  39. 39.
    Lambert J, Aarsen M, Denker AJM, Stehouwer CD A Endothelium-dependent and -independent vasodilation of large arteries in normoalbuminuric insulin-dependent diabetes mellitus. Arterioscl Thromb VascBiol 1996; 16: 705–711.CrossRefGoogle Scholar
  40. 40.
    Lehmann ED, Riley WA, Clarkson P, Gosling RG. Non-invasive assessment of cardiovascular disease in diabetes mellitus. Lancet 1997; 350 (suppl I):14–19.CrossRefGoogle Scholar
  41. 41.
    Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995; 332:635–641.PubMedCrossRefGoogle Scholar
  42. 42.
    Lorenzi M. Glucose toxicity in the vascular complications of diabetes; the cellular perspective. Diabetes Metab Rev 1992; 8: 85–103.PubMedCrossRefGoogle Scholar
  43. 43.
    Hattori Y, Kasai K, Nakamura T, Emoto T, Shimodi SI. Effect of glucose and insulin on immuno-reactive endothelin-1 release from cultured porcine aortic endothelial cells. Metabolism 1991; 40:165–169.PubMedCrossRefGoogle Scholar
  44. 44.
    Takahashi K, Ghatei MA, Lam HC, O’Halloran DJ, Bloom SR. Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 1990; 33:306–310.PubMedCrossRefGoogle Scholar
  45. 45.
    Conlan MG, Folsom AR, Finch A, et al. Associations of factor VIII and von Willebrand factor with age, race, sex and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 1993; 70:380–385.PubMedGoogle Scholar
  46. 46.
    Baron AD. The coupling of glucose metabolism and perfusion in human skeletal muscle. The potential role of endothelium-derived nitric oxide. Diabetes 1996; 45: Suppl. 1: S105-S109.Google Scholar
  47. 47.
    Polderman KH, Stehouwer CDA, van Kamp GJ, Gooren LJG. Effects of insulin infusion on endothelium-derived vasoactive substances. Diabetologia 1996; 39: 1284–1292.PubMedCrossRefGoogle Scholar
  48. 48.
    Niskanen L, Uuskupa M, Sarlund H, et al. Microalbuminuria predicts the development of serum lipoprotein abnormalities favouring atherogenesis in newly diagnosed type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1990; 33:237–243.PubMedCrossRefGoogle Scholar
  49. 49.
    Hafimer SM, Morales PA, Gruber MK, Hazuda HP, Stem MP. Cardiovascular risk factors in non-insulin-dependent diabetic subjects with microalbuminuria. Arteriosclerosis Thromb 1993; 13:205–210.CrossRefGoogle Scholar
  50. 50.
    Smulders YM, Rakic M, Stehouwer CDA, Weijers RNM, Slaats EH, Silberbusch J. Determinants of progression of microalbuminuria in patients with NIDDM. Diabetes Care 1997; 20:999–1005.PubMedCrossRefGoogle Scholar
  51. 51.
    Semé EH, Stehouwer CDA, ter Maaten JC, et al. Insulin resistance and hypertension: Role for microcirculation? Diabetologia 1997; 40 (suppl. 1): A246 (abstract).Google Scholar
  52. 52.
    Rattigan S, Clark MG, Barrett EJ. Hemodynamic actions of insulin in rat skeletal muscle. Evidence for capillary recruitment. Diabetes 1997; 46: 1381–1388.PubMedCrossRefGoogle Scholar
  53. 53.
    Castillo C, Bogardus C, Bergman R, et al. Interstitial insulin concentrations determine glucose uptake rates but not insulin resistance in lean and obese men. J Clin Invest 1994; 93: 10–16.PubMedCrossRefGoogle Scholar
  54. 54.
    Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1 mediated inhibition of insulin receptor tyrosine kinase activity in TNF-a and obesity-induced insulin resistance. Science 1996; 271:665–668.PubMedCrossRefGoogle Scholar
  55. 55.
    Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW. Insulin resistance syndrome and endothelial damage — role of adipose tissue derived pro-inflammatory cytokines. Diabetologia 1997; 40 (suppl.l): A305(abstract)Google Scholar
  56. 56.
    Stephenson JM, Fuller JH, Viberti G-C, Sjolie A-K, Navalesi R, the EURODIAB IDDM Complications Study Group. Blood pressure, retinopathy and urinary albumin excretion in IDDM: The EURODIAB IDDM Complications Study. Diabetologia 1995; 38:599–603.PubMedCrossRefGoogle Scholar
  57. 57.
    Greaves M, Malia RG, Goodfellow K, et al. Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM complications study. Diabetologia 1997; 40:698–705.PubMedCrossRefGoogle Scholar
  58. 58.
    Parving HH, Gall MA, Skott P, et al. Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int 1992; 41:758–762.PubMedCrossRefGoogle Scholar
  59. 59.
    Fioretto P, Mauer M, Brocco E et al. Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia 1996; 39:1569–1576.PubMedCrossRefGoogle Scholar
  60. 60.
    Fioretto P, Stehouwer CDA, Mauer M, et al. Heterogeneous nature of microalbuminuria in NIDDM: Studies of endothelial function and renal structure. Diabetologia 1998 41:233–236.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1998

Authors and Affiliations

  • Coen D. A. Stehouwer
    • 1
  1. 1.Department of MedicineFree University HospitalAmsterdamThe Netherlands

Personalised recommendations